FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

17319911000001107: Qutenza 179mg cutaneous patches (Astellas Pharma Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 28-Jul 2010. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
60185201000001114 Qutenza 179mg cutaneous patches (Astellas Pharma Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
104331801000001110 Qutenza 179mg cutaneous patches (Grunenthal Ltd) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Qutenza 179mg cutaneous patches (Astellas Pharma Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Qutenza 179mg cutaneous patches (Astellas Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Qutenza 179mg cutaneous patches (Astellas Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Qutenza 179mg cutaneous patches (Astellas Pharma Ltd) Is a Capsaicin 179mg cutaneous patches true Inferred relationship Existential restriction modifier
Qutenza 179mg cutaneous patches (Astellas Pharma Ltd) Has active ingredient Capsaicin true Inferred relationship Existential restriction modifier
Qutenza 179mg cutaneous patches (Astellas Pharma Ltd) Has manufactured dose form Cutaneous AND/OR transdermal dosage form false Inferred relationship Existential restriction modifier
Qutenza 179mg cutaneous patches (Astellas Pharma Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Qutenza 179mg cutaneous patches (Astellas Pharma Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Qutenza 179mg cutaneous patches (Astellas Pharma Ltd) Has specific active ingredient Capsaicin true Inferred relationship Existential restriction modifier
Qutenza 179mg cutaneous patches (Astellas Pharma Ltd) Has dispensed dose form Cutaneous patch false Inferred relationship Existential restriction modifier
Qutenza 179mg cutaneous patches (Astellas Pharma Ltd) Has excipient Excipient not declared false Inferred relationship Existential restriction modifier
Qutenza 179mg cutaneous patches (Astellas Pharma Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Qutenza 179mg cutaneous patches (Astellas Pharma Ltd) Is a Qutenza true Inferred relationship Existential restriction modifier
Qutenza 179mg cutaneous patches (Astellas Pharma Ltd) Has dispensed dose form Cutaneous patch true Inferred relationship Existential restriction modifier
Qutenza 179mg cutaneous patches (Astellas Pharma Ltd) Has excipient Edetate disodium false Inferred relationship Existential restriction modifier
Qutenza 179mg cutaneous patches (Astellas Pharma Ltd) Has excipient Butylated hydroxyanisole false Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Qutenza 179mg cutaneous patches (Astellas Pharma Ltd) 1 patch Has AMP True Qutenza 179mg cutaneous patches (Astellas Pharma Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start